An immunohistochemical study of leu 7 and PCNA expression in thyroid neoplasms

Biotechnic and Histochemistry

Volumn 71, Issue 6, 1996, Pages 298-303

  Fucich, Lee F ^a   Freeman, Scott M ^a   Marrogi, Aizen J ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

immunohistochemistry; leu 7; PCNA; thyroid neoplasms

Indexed keywords

CYCLINE;

ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TISSUE SECTION;

EID: 0029829727     PISSN: 10520295     EISSN: None     Source Type: Journal    
DOI: 10.3109/10520299609117179     Document Type: Article

References (23)

1. Abo. T. and Balch, C. M. 1981. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J. Immunol. 127: 1024-1029.
2. Adams, R. A., Flowers, A. and Davis. B. J. 1968. Direct implantation of human acute lymphoblastic leukemia in hamsters, SB-2. Cancer Res. 28: 1121-1124.
3. Bunn. P. A., Linnoila, I., Minna, J. D., Carney, D. and Gazdar, A. F. 1985. Small cell lung cancer, endocrine cells of the fetal bronchus and other neuroendocrine cells express the leu-7 antigenic determinant present on natural killer cells. Blood 65: 764-768.
4. Caillaud, J-M., Benjelloun, S., Bosq, J., Braham, K. and Lipinski, M. 1984. HNK-1 defined antigen detected in paraffin-embedded neuroectodermal tumors and those derived from cells of the amine precursor uptake and decarboxylation system. Cancer Res. 44: 4432-4434.
5. Coltrera, M. D., Skelly, M. and Gowen, A. M. 1993. Anti-PCNA antibody PC10 yields unreliable proliferation indices in routinely processed deparaffinized, formalin-fixed tissue. Appl. Immunohistochem. 1: 193.
6. Di Sant'Agnese, P. A. and De'Mesy Jensen, J. L. 1984. Endocrine-paracrine cells of the prostate and prostatic urethra. An ultrastructural study. Hum. Pathol. 15: 1034.
7. El-Habashi, A., Freeman, S. M., El-Didi, M. and Marrogi, A. J. 1996. DNA Ploidy and PCNA image analysis of peritoneal and pleural effusions. A possible diagnostic role. Acta. Cytol. In press.
8. Ghali, V. S., Jimenez, E. J. S. and Garcia, R. L. 1992. Distribution of leu-7 antigen (HNK-1 ) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas. Hum. Pathol. 23: 21-25.
9. Gowen, A. M., DeWever, N. and Battifora, H. 1993. Microwave-based antigenic unmarking: a revolutionary new technique for routine immunohistochemistry. Appl. Immunohistochem. 1: 256.
10. Hall, P. A., Levison, D. A. and Wood, A. L. 1990. Proliferation cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 162: 285.
11. Hsu, S. M., Raine, L. and Fanger, H. 1981. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29: 577-80.
12. Kazzaz, B. A. 1974. Argentaffin and argyrophil cells in the prostate. J. Pathol. 112: 189.
13. Lanier, L. L., Le, A. M., Phillips, J. H., Warner, N, L. and Babcock, G. F. 1983. Subpopulations of human natural killer cells defined by expression of the leu-7 (HNK-1) and leu-11 (NK-15) antigens. J. Immunol. 131: 1789-1796.
14. Lipinski, M., Braham, K., Caillaud, J. M., Carlu, C. and Tursz, T. 1983. Antibody (an antigen expressed on neuroectodermal cells). J. Exp. Med. 158: 1775.
15. Liu, X. H., Yoshiki, T., Kokuho, M., Okada, Y., Tomoyoshi, T. and Higuchi, K. 1993. The prognostic value of the HNK-1 (Leu-7) antigen in prostatic cancer: an immunohistochemical study. Acta. Urol. Jpn. 39: 439-444.
16. Loy, T. S., Darkow, G. V. D., Spollen, L. E. and Diaz-Arias, A. A. 1994. Immunostaining for leu-7 in the diagnosis of thyroid carcinoma. Arch. Pathol. Lab. Med. 118: 172-174.
17. May, E. E. and Perentes, E. 1986. Anti-leu-7 immunoreactivity with human tumours: its value in the diagnosis of prostatic adenocarcinoma. Histopathology 11: 295-304.
18. McGarry, R. C., Helfand, S. L., Quarles, R. H. and Roder, J. C. 1983. Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature 306: 376-378.
19. Mechtersheimer, G., Staudter, M. and Moller, P. 1991. Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res. 51: 1300-1307.
20. Morris, G. F. and Matthews, M. B. 1989. Regulation of proliferating cell nuclear antigen during cell cycle. J. Cell Biol. 264: 13856.
21. Rusthoven, J. J., Robinson, J. B., Kolin, A. and Pinkerton, P. H. 1985. The natural-killer-cell-associated HNK-1 (leu-7) antibody reacts with hypertrophic and malignant prostatic epithelium. Cancer 56: 289-293.
22. Shimizu, T., Usuda, N., Yamanda, T., Sugenoya, A. and Iida, F. 1993. Proliferative activity of human thyroid tumors evaluated by proliferative cell nuclear antigen/cyclin immunohistochemical studies. Cancer 71: 2807-2812.
23. Wahab, Z. A. and Wright, G. L. 1985. Monoclonal antibody (anti-leu-7) directed against natural killer cells reacts with normal, benign and malignant prostate tissues. Int. J. Cancer 36: 677-683.